Brief: Atara Biotherapeutics Inc - On May 12, Jakob Dupont Resigned From The Company As Executive Vice President, Global Head Of Research And Development
Atara Biotherapeutics Inc ATRA.O :
* ATARA BIOTHERAPEUTICS INC - ON MAY 12, JAKOB DUPONT
RESIGNED
FROM THE COMPANY AS EXECUTIVE VICE PRESIDENT, GLOBAL HEAD OF
RESEARCH AND DEVELOPMENT
Source text for Eikon: ID:
Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM